VXUS vs XBI
Vanguard Total International Stock ETF vs SPDR S&P Biotech ETF
- • VXUS has the lower expense ratio at 0.05% vs 0.35% for XBI.
- • VXUS pays a higher dividend yield (2.56%).
Side-by-side metrics
| Metric | VXUS | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.56% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $650.32B | $10.73B |
YTD return | 12.55% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 1.10 |
P/E ratio | 17.86 | — |
Last price | $85.11 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VXUS top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 3.98% |
| 005930.KS | Samsung Electronics Co Ltd | 2.19% |
| 000660.KS | SK Hynix Inc | 1.86% |
| ASML.AS | ASML Holding NV | 1.39% |
| 0700.HK | Tencent Holdings Ltd | 0.74% |
| HSBA.L | HSBC Holdings PLC | 0.71% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 0.65% |
| NOVN.SW | Novartis AG Registered Shares | 0.64% |
| AZN.L | AstraZeneca PLC | 0.62% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 0.61% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VXUS
VXUS (Vanguard Total International Stock ETF) is All non-US equities (developed + emerging). Managed by Vanguard, the fund carries $650.3B in assets under management, an expense ratio of 0.05%, a dividend yield of 2.56%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.